BioVie Inc. Announces Pricing of Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
BioVie Inc. (NASDAQ: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological ...
Nuclear Fuels Closes Private Placement with Newly Appointed Director
Nuclear Fuels Inc. (CSE: NF) (OTCQX: NFUNF) ("Nuclear Fuels" or the "Company") announced today it has closed its non-brokered ...
bioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private Placement
SAN ANTONIO, October 21, 2024--bioAffinity Technologies announces closing of $2.6 million registered direct offering and ...
GlobalData on MSN5d
NGEx Minerals to raise $72m in private placement
The company plans to use the proceeds to support exploration at the Lunahuasi project in Argentina and the Los Helados ...
XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement
A.G.P./Alliance Global Partners acted as sole placement agent for the Offering.
T-Net5d
Kelowna-based Lexaria Closes $5 Million Financing via Private Placement (Registered Direct Offering)
Bioscience Corp. (Nasdaq:LEXX; LEXXW), a developer of drug delivery platforms, today announced that it has closed a ...
Eminent Gold Corp. Announces Closing of Final Tranche of Private Placement Including Increase in Size of Private Placement to $2.43 million
The Units issued pursuant to the second tranche of the Offering are subject to a four-month hold period under applicable Canadian securities laws that expires February 16, 2025.
Business Wire4d
bioAffinity Technologies Announces Pricing of $2.66 Million Registered Direct Offering & Concurrent Private Placement
Affinity Technologies announces pricing of $2.66 million registered direct offering and concurrent private placement.